Investors
Adimmune Corporation is a publicly traded company on the Taiwan Stock Exchange (TWSE)
Corporate Governance
Content
-
1.Articles of Incorporation
-
2.The 22nd Executive Committee
-
2.1Disclosure of Professional Qualifications of Board Members and Independence of Independent Director
-
3.Audit Committee Charter
-
4.The 4th Audit Committee
-
4.1Operational Status
-
5.Remuneration Committee Charter
-
6.Remuneration Committee CV
-
6.1Operational Status
-
7.Charter of the Board Risk Management Committee
-
8.Risk Management Committee CV
-
8.1Risk Management Committee Operational Status
-
9.Rules for Performance Evaluation of Board of Directors
-
9.1 2024 Report for Performance Evaluation of Board of Directors
-
9.2 External Evaluation
-
9.3 Description of the 2025 Board of Directors Performance Evaluation (External Evaluation)
-
10.Corporate Governance Best Practice Principles
-
10.1.2025 Corporate Governance Supervisor’s Annual Continuing Education
-
11.1 Adimmune Corporation Organizational Charter of the Sustainable Development Committee
-
11.2 The 1st Sustainable Development Committee
-
11.3 Annual Key Responsibilities of the Sustainable Development Committee
-
11.4 Operational Status
-
12.2025 List of Major Shareholders
-
13. Anti-Corruption Policy
-
14. Procedures for Handling Material Inside Information and the Prevention of Insider Trading